Download PDF
Seminars in Neurosurgery 2001; 12(3): 337-344
DOI: 10.1055/s-2001-33625
Copyright © 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

The Role of Radiation Therapy and Stereotactic Radiosurgery in the Treatment of Pituitary Adenomas

Douglas Kondziolka, Ajay Niranjan, Jason P. Sheehan, John C. Flickinger, L. Dade Lunsford
  • 1Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania
  • 2Department of Radiation Oncology, University of Pittsburgh, Pittsburgh, Pennsylvania
  • 3The Center for Image Guided Neurosurgery, University of Pittsburgh, Pittsburgh, Pennsylvania
Further Information

Publication History

Publication Date:
27 August 2002 (online)

    Permissions and Reprints

ABSTRACT

Pituitary tumors can be managed with medication, surgical resection, radiation therapy (XRT), and stereotactic radiosurgery. Radiation approaches are best suited for patients with residual tumors after prior resection, particularly when the tumor involves the cavernous sinus. Irradiation can also be useful for patients with persistent hormone-secreting tumors despite resection or in those for whom resection would be associated with excessive risk. In this report, we review the rationale behind the various radiation approaches and discuss the risks and benefits of radiosurgery and XRT.

KEYWORDS

Pituitary tumor - radiosurgery - radiation therapy - acromegaly - Cushing's disease

REFERENCES

  • 1 Sheline G E, Goldberg M B, Feldman R. Pituitary irradiation for acromegaly.  Radiology . 1961;  76 70-82
    PubMedGoogle Scholar
  • 2 Sheline G E, Tyrell J B. Pituitary adenomas. In: Phillips TC, Pistenma DA, eds. Radiation Oncology Annual New York: Raven Press 1983
    Google Scholar
  • 3 Cohen A R, Cooper P R, Kupersmith M J. Visual recovery after transsphenoidal removal of pituitary adenomas.  Neurosurgery . 1985;  17 446-452
    PubMedGoogle Scholar
  • 4 Rush S, Kupersmith M J, Leuch I. Neuroophthalmologic assessment of vision before and after radiation therapy alone for pituitary macroadenomas.  J Neurosurg . 1990;  72 594-599
    PubMedGoogle Scholar
  • 5 Degerblad M, Rahn T, Bergstrand G. Long-term results of stereotactic radiosurgery to pituitary gland in Cushing's disease.  Acta Endocrinologica . 1986;  112 310-314
    PubMedGoogle Scholar
  • 6 Ganz J C, Backlund E O, Thorsen F A. The effects of gamma knife surgery of pituitary adenomas on tumor growth and endocrinopathies.  Stereotact Funct Neurosurg . 1993;  30-37
    PubMedGoogle Scholar
  • 7 Pollock B E, Kondziolka D, Lunsford L D, Flickinger J C. Stereotactic radiosurgery for pituitary adenomas: imaging, visual and endocrine results.  Acta Neurochir . 1994;  62(suppl) 5-10
    PubMedGoogle Scholar
  • 8 Rahn T, Thoren M, Werner S. Stereotactic radiosurgery in pituitary adenomas. In: Faglia G, Beck-Peccoz P, Ambrosi B, Travaglini P, Spada A, eds. Pituitary Adenomas: New Trends in Basic and Clinical Research New York: Excerpta Medica 1991: 303-312
    Google Scholar
  • 9 Witt T, Kondziolka D, Flickinger J. Stereotactic radiosurgery for pituitary tumors.  Radiosurgery . 1996;  1 55-65
    PubMedGoogle Scholar
  • 10 Duma C M, Lunsford L D, Kondziolka D, Harsh G R, Flickinger J C. Stereotactic radiosurgery of cavernous sinus meningiomas as an addition or alternative to microsurgery.  Neurosurgery . 1993;  32 699-705
    CrossrefPubMedGoogle Scholar
  • 11 Kondziolka D, Lunsford L D, Flickinger J C. Current concepts in gamma knife radiosurgery.  Neurosurg Quarterly . 1993;  3 253-271
    PubMedGoogle Scholar
  • 12 Flickinger J C, Deutsch M, Lunsford L D. Repeat megavoltage irradiation of pituitary and suprasellar tumors.  Int J Radiat Oncol Biol Phys . 1989;  17 717-175
    PubMedGoogle Scholar
  • 13 Flickinger J C, Nelson P B, Martinez A J. Radiotherapy of nonfunctional adenomas of the pituitary gland.  Cancer . 1989;  63 2409-2413
    PubMedGoogle Scholar
  • 14 Brada M, Rajan B, Traish D. The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas.  Clin Endocrinol . 1993;  38 571-578
    CrossrefPubMedGoogle Scholar
  • 15 Ludecke D K, Lutz B S, Niedwovok G. The choice of treatment in incomplete adenomectomy in acromegaly: proton versus high voltage radiation.  Acta Neurochir . 1989;  96 32-38
    CrossrefPubMedGoogle Scholar
  • 16 Rush S C, Newall J. Pituitary adenoma: the efficacy of radiotherapy as the sole treatment.  Int J Radiat Oncol Biol Phys . 1989;  17 165-169
    PubMedGoogle Scholar
  • 17 Bowen J, Paulsen C A. Stroke after pituitary irradiation.  Stroke . 1992;  23 908-911
    PubMedGoogle Scholar
  • 18 Flickinger J C, Kalend A. Use of normalized total dose to represent the biological effect of fractionated radiotherapy.  Radiother Oncol . 1990;  17 339-347
    PubMedGoogle Scholar
  • 19 Flickinger J C, Lunsford L D, Singer J, Cano E R, Deutsch M. Megavoltage external beam irradiation of craniopharyngiomas: analysis of tumor control and morbidity.  Int J Radiat Oncol Biol Phys . 1990;  19 117-122
    PubMedGoogle Scholar
  • 20 Flickinger J C, Nelson P B, Taylor F H. Incidence of cerebral infarction after radiotherapy for pituitary adenoma.  Cancer . 1989;  63 2404-2408
    PubMedGoogle Scholar
  • 21 Grattan-Smith P J, Morris J G, Langlands A O. Delayed radiation necrosis of the central nervous system in patients irradiated for pituitary tumors.  J Neurol Neurosurg Psychiatry . 1992;  55 949-955
    PubMedGoogle Scholar
  • 22 Littley M D, Shalet S M, Beardwell C G, Ahmed S R, Applegate G, Sutton M L. Hypopituitarism following external radiotherapy for pituitary tumors in adults.  Q J Med . 1989;  70(262) 145-160
    PubMedGoogle Scholar
  • 23 Sheline G, Wara W, Smith V. Therapeutic irradiation and brain injury.  Int J Radiat Oncol Biol Phys . 1980;  6 1215-1228
    CrossrefPubMedGoogle Scholar
  • 24 Wigg D R, Murray M L, Koschel K. Tolerance of the central nervous system to photon irradiation: endocrine complications.  Acta Radiol Oncol 21 Fasc . 1982;  1 49-60
    PubMedGoogle Scholar
  • 25 Barrow D L, Tindall G T, Kovacs K. Clinical and pathologic effects of bromocriptine on prolactin-secreting and other pituitary tumors.  J Neurosurgery . 1984;  60 1-7
    PubMedGoogle Scholar
  • 26 Molitch M E, Celton R L, Blackwell R E. Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study.  J Clin Endocrinol Metabol . 1985;  60 698-705
    PubMedGoogle Scholar
  • 27 Mehta A E, Reyes F L, Faihnern C. Primary radiotherapy of prolactinomas.  Am J Med . 1989;  83 59-68
    PubMedGoogle Scholar
  • 28 Rush S, Donahue B, Cooper P. Prolactin reduction after combined modality therapy for prolactin macroadenomas.  Neurosurg . 1991;  28 502-505
    PubMedGoogle Scholar
  • 29 Trampe E A, Lundell G, Lax I, Werner S. External irradiation of growth hormone producing pituitary adenomas: prolactin as a marker of hypothalamic and pituitary effects.  Int J Radiat Oncol Biol Phys . 1991;  20 655-660
    PubMedGoogle Scholar
  • 30 Tsagarakis S, Grossman A, Plowman P N. Megavoltage pituitary irradiation in the management of prolactinomas: long-term follow-up.  Clin Endocrinol . 1991;  34 399-406
    PubMedGoogle Scholar
  • 31 Tsang R W, Brierley J, Panzarella T. Role of radiation therapy in clinical hormonally active pituitary adenomas.  Radiother Oncol . 1996;  41 45-53
    PubMedGoogle Scholar
  • 32 Caruso M, Shaw E, Davis D. Radiation treatment of growth hormone-secreting pituitary adenomas.  Int J Radiat Oncol Biol Phys . 1993;  21 121-122
    PubMedGoogle Scholar
  • 33 Tran L M, Blount L, Horton D. Radiation therapy of pituitary tumors: results in 95 cases.  Am J Clin Oncol . 1991;  14 25-29
    PubMedGoogle Scholar
  • 34 Werner S, Trampe E, Palacios P. Growth hormone producing pituitary adenomas with concomitant hypersecretion of prolactin are particularly sensitive to photon irradiation.  Int J Radiat Oncol Biol Phys . 1985;  11 1713-1720
    PubMedGoogle Scholar
  • 35 Eastman R C, Gorden P, Roth J. Conventional supervoltage irradiation is an effective treatment for acromegaly.  J Clin Endocrin Metab . 1979;  48 931-940
    PubMedGoogle Scholar
  • 36 Schoenthaler R, Albright N W, Wara W M. Re-irradiation of pituitary adenoma.  Int J Radiat Oncol Biol Phys . 1992;  24 307-314
    PubMedGoogle Scholar
  • 37 Sheline G E, Wara W M. Radiation therapy of acromegaly and nonsecretory chromophobe adenomas of the pituitary. In: Seydel HG, ed. Tumors of the Central Nervous System New York: John Wiley and Sons 1975: 119-131
    Google Scholar
  • 38 Clarke S D, Woo S Y, Buther E B. Treatment of secretory pituitary adenoma with radiation therapy.  Radiology . 1993;  188 759-763
    PubMedGoogle Scholar
  • 39 Doban F C, Raventos A, Boucot N. Roentgen therapy on Cushing syndrome without adrenocortical tumor.  J Clin Endocrinol Metab . 1957;  17 8
    PubMedGoogle Scholar
  • 40 Edmonds M W, Simpson W J, Meakeh J W. External irradiation of the hypophysis for Cushing's disease.  Cal Med Assn J . 1972;  107 860
    PubMedGoogle Scholar
  • 41 Grigsby P W, Simpson J R, Stokes S. Results of surgery and irradiation or irradiation alone for pituitary adenomas.  J Neurooncol . 1988;  6 129-134
    PubMedGoogle Scholar
  • 42 Heuschele R, Lampe I. Pituitary irradiation for Cushing's syndrome.  N Engl J Med . 1967;  285 243
    PubMedGoogle Scholar
  • 43 Estrada J, Boronat M, Mielgo M. The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease.  N Engl J Med . 1997;  336 172-177
    CrossrefPubMedGoogle Scholar
  • 44 McCollough W M, Marcus Jr B R, Rhoton Jr L A. Long-term follow-up of radiotherapy for pituitary adenoma: the absence of late recurrence after greater than or equal to 4500 cGy.  Int J Radiat Oncol Biol Phys . 1991;  21 607-614
    PubMedGoogle Scholar
  • 45 Nelson P B, Goodman M L, Flickinger J C. Endocrine function in patients with large pituitary tumors treated with operative decompression and radiation therapy.  Neurosurg . 1989;  24 398-400
    PubMedGoogle Scholar
  • 46 Sheline G E. The role of conventional radiation therapy in the treatment of functional pituitary tumors. In: Linfoot JA, ed. Recent Advances in the Diagnosis and Treatment of Pituitary Tumors New York: Raven Press 1979: 289-313
    Google Scholar
  • 47 Ciric I, Mikhael M, Stafford T. Transsphenoidal neurosurgery of pituitary macroadenomas with long-term follow-up results.  J Neurosurgery . 1983;  59 395-401
    CrossrefPubMedGoogle Scholar
  • 48 Laws Jr R E, Trautman J C, Hollenhorst Jr W R. Transsphenoidal decompression of the optic nerve and chiasm: visual results in 62 patients.  J Neurosurg . 1977;  46 717-722
    PubMedGoogle Scholar
  • 49 Fisher B J, Gaspar L E, Noone B. Radiation therapy of pituitary adenoma: delayed sequelae.  Radiology . 1993;  187 843-846
    PubMedGoogle Scholar
  • 50 Tsang R W, Laperriere N J, Simpson W J. Glioma arising after radiation therapy for pituitary adenoma: a report of four patients and estimation of risk.  Cancer . 1993;  72 2227-2233
    PubMedGoogle Scholar
  • 51 Kjellberg R N, Kliman B. Lifetime effectiveness: a system of therapy for pituitary adenomas, emphasizing Bragg peak proton hypophysectomy. In: Linfoort JA, ed. Recent Advances in the Diagnosis and Treatment of Pituitary Tumors New York: Raven Press 1979: 269-288
    Google Scholar
  • 52 Levy R P, Fabrikand J I, Frankel K A. Heavy-charged-particle radiosurgery of the pituitary gland: clinical results of 840 patients.  Stereotact Funct Neurosurg . 1991;  57 22-35
    PubMedGoogle Scholar
  • 53 Backlund E O, Rahn T, Sarby D, de Schryver A, Wennnerstrand J. Closed stereotaxic hypophysectomy by means of 60-cobalt gamma radiation.  Acta Radiol Ther Phys Biol . 1972;  11 545-555
    PubMedGoogle Scholar
  • 54 Flickinger J C, Lunsford L D, Wu A, Maitz A H, Kalend A M. Treatment planning for gamma knife radiosurgery with multiple isocenters.  Int J Radiat Oncol Biol Phys . 1989;  18 1495-1501
    PubMedGoogle Scholar
  • 55 Flickinger J C, Maitz A, Kalend A, Lunsford L D, Wu A. Treatment volume shaping with selective beam blocking using the Leksell gamma unit.  Int J Radiat Oncol Biol Phys . 1990;  19 783-789
    PubMedGoogle Scholar
  • 56 Flickinger J C, Lunsford L D, Kondziolka D. Dose prescription and dose-volume effects in radiosurgery.  Neurosurg Clin North Am . 1992;  3 51-59
    PubMedGoogle Scholar
  • 57 Stephanian E, Lunsford L D, Coffey R J, Bissonette D J, Flickinger J C. Gamma knife surgery for sellar and suprasellar tumors.  Neurosurg Clin North Am . 1992;  3 207-218
    PubMedGoogle Scholar
  • 58 Hoybye C, Grenblack E, Rahn T. Adrenocorticotropic hormone-producing pituitary tumors: 12- to 22-year follow-up after treatment with stereotactic radiosurgery.  Neurosurg . 2001;  49 284-292
    CrossrefPubMedGoogle Scholar
  • 59 Sheehan J M, Vance M L, Sheehan J P. Radiosurgery for Cushing's disease after failed transsphenoidal surgery.  J Neurosurg . 2000;  93 738-742
    CrossrefPubMedGoogle Scholar
  • 60 Landolt A M, Haller D, Lomax N. Stereotactic radiosurgery for recurrent surgically treated acromegaly: comparison with fractionated radiotherapy.  J Neurosurg . 1998;  88 1002-1008
    PubMedGoogle Scholar
  • 61 Landolt A M, Haller D, Lomax N. Octreotide may act as a radioprotective agent in acromegaly.  J Clin Endocrinol Metab . 2000;  85 1287-1289
    CrossrefPubMedGoogle Scholar
  • 62 Ikeda H, Jokura H, Yoshimoto T. Transsphenoidal surgery and adjuvant gamma knife treatment for growth hormone- secreting pituitary adenoma.  J Neurosurg . 2001;  95 285-291
    PubMedGoogle Scholar